Mathieu Ferrari
Impact in
-
- Rheumatoid Arthritis Research and Therapies
Papers in
- Oncology 11
- CAR-T cell therapy research 6
- HER2/EGFR in Cancer Research 3
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Shimobi Onuoha (15 shared papers)Costantino Pitzalis (8 shared papers)Martin Pulé (12 shared papers)Daniele Sblattero (5 shared papers)M. Taraborelli (2 shared papers)Roberta Cattaneo Horn (2 shared papers)Silvana Archetti (2 shared papers)Laura Andréoli (2 shared papers)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)Blood (2 papers)Scientific Reports (1 paper)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Mathieu Ferrari
26 papers receiving 269 citations
Peers
Comparison fields: 5 of 59
- Rheumatology 71
- Immunology 81
- Radiology, Nuclear Medicine and Imaging 69
- Genetics 28
- Oncology 64
Countries citing papers authored by Mathieu Ferrari
This map shows the geographic impact of Mathieu Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Ferrari more than expected).
Fields of papers citing papers by Mathieu Ferrari
This network shows the impact of papers produced by Mathieu Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Ferrari. The network helps show where Mathieu Ferrari may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Ferrari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 53 | |
| 2 | 2014 | 29 | |
| 3 | Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. | 2009 | 26 |
| 4 | 2021 | 25 | |
| 5 | 2015 | 17 | |
| 6 | 2020 | 16 | |
| 7 | 2024 | 13 | |
| 8 | 2021 | 13 | |
| 9 | 2011 | 13 | |
| 10 | 2015 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2018 | 8 | |
| 13 | 2021 | 7 | |
| 14 | BAEP and E.M.G. changes from whiplash injuries. | 1994 | 7 |
| 15 | 2020 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2011 | 1 |
About Mathieu Ferrari
Mathieu Ferrari is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology and Rheumatology, having authored 27 papers that have together received 278 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers), CAR-T cell therapy research (6 papers), Acute Lymphoblastic Leukemia research (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), HER2/EGFR in Cancer Research (3 papers), SARS-CoV-2 detection and testing (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Rheumatology (71 citations), Immunology (81 citations), Radiology, Nuclear Medicine and Imaging (69 citations), Genetics (28 citations) and Oncology (64 citations). Mathieu Ferrari has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Shimobi Onuoha, Costantino Pitzalis, Martin Pulé, Daniele Sblattero, M. Taraborelli, Roberta Cattaneo Horn, Silvana Archetti, Laura Andréoli, Reyisa Bughda and Anǵela Tincani. Their work appears in journals such as Annals of the Rheumatic Diseases, Frontiers in Immunology, Cancer Research, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.